Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
用户v-FxP-miV5Ik
1个月前
108
10
已完结
1. 系统已在2026-06-24 16:33:51对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202501111
其他信息:
出版社: Wiley
作者: Chao Tang; Bin Tian; Bingxing Zhang; Yunfei Zhang; Changhua Ke; Mengxin Chen; Meiyan Wei; Wen Wang; Xintao Deng; Qiannan Zhang; Mengzhou Wang; Juan Xia; Meiling He; Chengyuan Liang; Lei Tian
全文下载地址: https://chemistry-europe.onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202501111
